These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7066357)

  • 1. Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside.
    Gherardi E; Calandra S
    Biochim Biophys Acta; 1982 Feb; 710(2):188-96. PubMed ID: 7066357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High density lipoproteinuria in nephrotic syndrome.
    de Mendoza SG; Kashyap ML; Chen CY; Lutmer RF
    Metabolism; 1976 Oct; 25(10):1143-9. PubMed ID: 184367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascites fluid lipoproteins in experimental nephrotic syndrome.
    Garber DW; Marsh JB
    Biochim Biophys Acta; 1988 Apr; 959(3):253-61. PubMed ID: 3355849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin.
    Calandra S; Tarugi P; Ghisellini M; Gherardi E
    Exp Mol Pathol; 1983 Dec; 39(3):282-99. PubMed ID: 6416889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome.
    Calandra S; Gherardi E; Fainaru M; Guaitani A; Bartosek I
    Biochim Biophys Acta; 1981 Aug; 665(2):331-8. PubMed ID: 6793079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside. Plasma and urinary lipoproteins.
    Gherardi E; Vecchia L; Calandra S
    Exp Mol Pathol; 1980 Apr; 32(2):128-42. PubMed ID: 7364013
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside: hepatic synthesis of lipoproteins and apolipoproteins.
    Gherardi E; Messori M; Rozzi R; Calandra S
    Lipids; 1980 Oct; 15(10):858-63. PubMed ID: 7442475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid metabolism in nephrotic rats induced by daunomycin injection.
    Morisaki N; Matsuoka N; Saito Y; Kumagai A
    Metabolism; 1984 May; 33(5):405-10. PubMed ID: 6717274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low density lipoprotein metabolism in rats with puromycin aminonucleoside-induced nephrotic syndrome.
    Joven J; Masana L; Villabona C; Vilella E; Bargalló T; Trias M; Figueras M; Turner PR
    Metabolism; 1989 May; 38(5):491-5. PubMed ID: 2725289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lowering effect of probucol on plasma lipoprotein and proteinuria in puromycin aminonucleoside-induced nephrotic rats.
    Hirano T; Mamo JC; Nagano S; Sugisaki T
    Nephron; 1991; 58(1):95-100. PubMed ID: 1857487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catabolic defect of triglyceride is associated with abnormal very-low-density lipoprotein in experimental nephrosis.
    Furukawa S; Hirano T; Mamo JC; Nagano S; Takahashi T
    Metabolism; 1990 Jan; 39(1):101-7. PubMed ID: 2294370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of non-HDL fraction to oxidation in experimental nephrotic syndrome.
    Dirican M; Taş S; Sarandöl E; Tokullugil HA
    Kobe J Med Sci; 1998 Dec; 44(5-6):235-45. PubMed ID: 10401226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid synthesis and apolipoprotein gene expression in hepatocytes in primary culture from (puromycin-induced) nephrotic rats.
    el Boustani S; Ribeiro A; Janvier B; Loriette C; Bensman R; Druet P; Chambaz J; Mangeney M
    Eur J Clin Invest; 1993 Apr; 23(4):211-8. PubMed ID: 8500513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on abnormal lipid metabolism in experimental nephrotic syndrome.
    Agbedana ED; Yamamoto T; Moriwaki Y; Suda M; Takahashi S; Higashino K
    Nephron; 1993; 64(2):256-61. PubMed ID: 8321360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of indomethacin on lymphocyte response to mitogens in puromycin aminonucleoside nephrosis in the rat.
    Garin EH; Barratt TM
    Clin Exp Immunol; 1982 Sep; 49(3):639-44. PubMed ID: 7172499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome.
    Tarugi P; Nicolini S; Albertazzi L; Calandra S; Salvati P; Ferti C; Patrono C
    J Lipid Res; 1991 Oct; 32(10):1675-87. PubMed ID: 1797947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dietary antioxidants on puromycin aminonucleoside nephrotic syndrome.
    Pedraza-Chaverri J; Arévalo AE; Hernández-Pando R; Larriva-Sahd J
    Int J Biochem Cell Biol; 1995 Jul; 27(7):683-91. PubMed ID: 7648424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the interrelationship between hepatic carnitine, fatty acid oxidation, and triglyceride biosynthesis in nephrosis.
    al-Shurbaji A; Berglund L; Berge RK; Cederblad G; Humble E
    Lipids; 1997 Aug; 32(8):847-52. PubMed ID: 9270976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of plasma lipid levels by plasma viscosity in nephrotic rats.
    Yedgar S; Eilam O; Shafrir E
    Am J Physiol; 1985 Jan; 248(1 Pt 1):E10-4. PubMed ID: 3966545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.